Haemocomplettan® P During Elective Complex Cardiac Surgery
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Fibrinogen concentrate is increasingly used in cardiac surgery to reverse coagulopathy.
Whether its use reduces blood loss, transfusion and occurrence of clinical adverse events
remains unknown.